Previous 10 | Next 10 |
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Hoptocopter/E+ via Getty Images Citing a peer-reviewed study published in the Journal of Infectious Diseases, the National Institute of Health says that both rapid antigen tests and PCR molecular tests have a high rate of sensitivity in detecting COVID-19. The PCR tests, considered the g...
TheCrimsonRibbon/iStock via Getty Images PerkinElmer ([[PKI]] -1.8%) is set to record its first intra-day loss in more than two weeks after the company’s 2023 guidance came below expectations. On its Virtual Investor and Analyst Day, PerkinElmer projected 2023 adjusted earnings per sha...
PerkinElmer (PKI) expects to beat prior Q2 guidance of $2.35 and $1.11 billion in revenue vs. a consensus EPS of $2.44 and $1.12 billion in revenue.PerkinElmer will release its Q2 financial results after market close on Wednesday, July 28, 2021.Prior outlook. For further details see: Pe...
Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced ahead of this morning’s Virtual Investor and Analyst Day th...
PerkinElmer (PKI) to acquire privately held SIRION Biotech GmbH, a global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies.The acquisition is expected to close during Q3 2021. SIRION has established a strong licensing portfo...
Solutions to complement Company’s growing position in cell and gene therapy research and development PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH , a lead...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IHF. A list of cheap stocks. For further details see: IHF: Healthcare Dashboard For June
PerkinElmer is a healthcare solutions company with a long-track record of market beating returns. It's benefitted from COVID-19 testing, and is exploring promising new growth avenues. I highlight what makes the stock a Buy, along with the balance sheet, and other points worth cons...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...